Highly multiplexed live-cell GPCR arrays for drug discovery in glioma.

NIH RePORTER · NIH · R41 · $222,717 · view on reporter.nih.gov ↗

Abstract

Project summary/Abstract We will deploy an automated multiplexed live-cell assay to detect and quantify agonist and inverse-agonist activities against 55 GPCRs known to be upregulated or downregulated in human gliomas. The assay will be used to look for the secretion of effectors for any of the 55 receptors by 48 established glioma cell lines of the Human Glioblastoma Cell Culture Resource. This endeavor may yield new leads towards the development of anti-tumor therapeutics, and will provide a platform for detecting such leads in resected tumor tissue and in chemical or biologic libraries in future experiments.

Key facts

NIH application ID
10139682
Project number
1R41CA257114-01
Recipient
SPECTRAGENETICS
Principal Investigator
JONATHAN W JARVIK
Activity code
R41
Funding institute
NIH
Fiscal year
2021
Award amount
$222,717
Award type
1
Project period
2021-04-07 → 2022-05-31